高级检索
当前位置: 首页 > 详情页

Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Dept Cardiovasc Ctr, Beijing Tongren Hosp, Beijing 100730, Peoples R China [2]Harbin Med Univ, Dept Cardiol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150010, Heilongjiang, Peoples R China [3]Harbin Med Univ, Key Lab Myocardial Ischemia, Minist Educ, Harbin 150010, Heilongjiang, Peoples R China [4]First Hosp Harbin, Cardiovasc Dept, Harbin 150010, Heilongjiang, Peoples R China
出处:
ISSN:

关键词: heart failure miRNA long noncoding RNA competing endogenous RNA

摘要:
Heart failure (HF) is a principal cause of morbidity and mortality worldwide, affecting an estimated 38 million people. Although significant progress has been made with respect to the underlying molecular mechanisms, the role of the competing endogenous RNA (ceRNA) network in the pathogenesis of HF remains largely unknown. In this study, an HF-associated ceRNA network was constructed based on the differentially expressed long noncoding RNAs (lncRNAs), microRNAs (miRNAs) and mRNAs obtained, respectively, from the GSE77399, GSE104150 and GSE84796 datasets. The ceRNA network consisted of 12 lncRNA nodes, 43 miRNA nodes, 343 mRNA nodes and 530 edges. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that the ceRNA network was primarily enriched in the immune response, inflammatory response and T cell and B cell receptor signaling pathways. In addition, three lncRNAs (growth arrest specific 5, taurine upregulated 1 and HOX transcript antisense RNA) and three miRNAs [hsa-miRNA (miR)-26b-5p, hsa-miR-8485 and hsa-miR-940] with higher node degrees compared with other genes were selected as hub nodes. The expression of hub nodes in patients with HF was verified by reverse transcription-quantitative polymerase chain reaction analysis. The present study provided further insights into the important roles of the ceRNA network in HF development, and indicated the potential use of these hub nodes as diagnostic biomarkers and therapeutic targets.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Cardiovasc Ctr, Beijing Tongren Hosp, Beijing 100730, Peoples R China
通讯作者:
通讯机构: [2]Harbin Med Univ, Dept Cardiol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150010, Heilongjiang, Peoples R China [3]Harbin Med Univ, Key Lab Myocardial Ischemia, Minist Educ, Harbin 150010, Heilongjiang, Peoples R China [*1]Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang, Harbin, Heilongjiang 150010, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25498 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)